Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 12/20 | 0.68 |
| ▸ | TSHR | P16473 | 2/20 | 0.68 |
| ▸ | MEN1 | O00255 | 1/20 | 0.68 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.68 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.68 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.68 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.52 |
| ▸ | CA12 | O43570 | 1/20 | 0.42 |
| ▸ | CA1 | P00915 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | CA3 | P07451 | 1/20 | 0.42 |
| ▸ | CA4 | P22748 | 1/20 | 0.42 |
| ▸ | CA6 | P23280 | 1/20 | 0.42 |
| ▸ | CA5A | P35218 | 1/20 | 0.42 |
| ▸ | CA7 | P43166 | 1/20 | 0.42 |
| ▸ | CA9 | Q16790 | 1/20 | 0.42 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.42 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6131307 | 1.00 | DNM1 (0.68) | DNM1TSHRMEN1KMT2AALDH1A1 | |
| SCHEMBL1492463 | 1.00 | DNM1 (0.68) | DNM1TSHRMEN1KMT2AALDH1A1 | |
| Diaminooctane SCHEMBL6863570 | 1.00 | DNM1 (0.68) | DNM1TSHRMEN1KMT2AALDH1A1 | |
| SCHEMBL11772109 | 1.00 | DNM1 (0.68) | DNM1TSHRMEN1KMT2AALDH1A1 | |
| SCHEMBL3786344 | 1.00 | DNM1 (0.68) | DNM1TSHRMEN1KMT2AALDH1A1 | |
| SCHEMBL23576182 | 1.00 | DNM1 (0.68) | DNM1TSHRMEN1KMT2AALDH1A1 | |
| SCHEMBL15477623 | 1.00 | DNM1 (0.68) | DNM1TSHRMEN1KMT2AALDH1A1 | |
| SCHEMBL10627523 | 1.00 | DNM1 (0.68) | DNM1TSHRMEN1KMT2AALDH1A1 | |
| Hexadecylamine SCHEMBL3801211 | 1.00 | DNM1 (0.68) | DNM1TSHRMEN1KMT2AALDH1A1 | |
| SCHEMBL29153561 | 1.00 | DNM1 (0.68) | DNM1TSHRMEN1KMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4748832-A2 | LIPIDOIDS FOR NUCLEIC ACID TRANSFECTION AND USE THEREOF | Ustav Organicke Chemie a Biochemie AV CR, v.v.i. (CZ) | 2026-05-27 | — | — | EP | disclosed |
| EP-4031522-B1 | LIPIDOIDS FOR NUCLEIC ACID TRANSFECTION AND USE THEREOF | USTAV ORGANICKE CHEMIE A BIOCHEMIE AV CR V V I (CZ) | 2026-04-22 | — | — | EP | disclosed |
| US-12605464-B2 | Cyclohexane lipidoids for nucleic acid transfection and use thereof | USTAV ORGANICKE CHEMIE A BIOCHEMIE AV CR, V.V.I. (CZ) | 2026-04-21 | — | — | US | disclosed |
| US-12559450-B2 | Lipidoids for nucleic acid transfection and use thereof | USTAV ORGANICKE CHEMIE A BIOCHEMIE AV CR, V.V.I. (CZ) | 2026-02-24 | — | — | US | disclosed |
| US-20240335559-A1 | CYCLOHEXANE LIPIDOIDS FOR NUCLEIC ACID TRANSFECTION AND USE THEREOF | USTAV ORGANICKE CHEMIE A BIOCHEMIE AV CR, V.V.I. (CZ) | 2024-10-10 | — | — | US | disclosed |
| EP-4373804-A1 | CYCLOHEXANE LIPIDOIDS FOR NUCLEIC ACID TRANSFECTION AND USE THEREOF | Ustav Organicke Chemie a Biochemie AV CR v.v.i. (CZ) | 2024-05-29 | — | — | EP | disclosed |
| CN-117413027-A | Resin composition and method for producing same | 旭化成株式会社 | 2024-01-16 | — | — | CN | disclosed |
| US-20230265049-A1 | Lipidoids for Nucleic Acid Transfection and Use Thereof | USTAV ORGANICKE CHEMIE A BIOCHEMIE AV CR, V.V.I. (CZ) | 2023-08-24 | — | — | US | disclosed |
| CN-116617862-A | Modification method of functional isocyanate crosslinking agent on surface of aromatic polyamide composite membrane | 江苏海洋大学 | 2023-08-22 | — | — | CN | disclosed |
| CN-116396523-A | Method for grafting ammonium phenolate zwitterionic on surface of aromatic polyamide composite membrane | 江苏海洋大学 | 2023-07-07 | — | — | CN | disclosed |
| WO-2023001323-A1 | CYCLOHEXANE LIPIDOIDS FOR NUCLEIC ACID TRANSFECTION AND USE THEREOF | Ustav Organicke Chemie A Biochemie AV CR v.v.i. (CZ) | 2023-01-26 | — | — | WO | disclosed |
| CN-114945556-A | Lipidoids for nucleic acid transfection and uses thereof | 捷克有机化学和生物化学研究院 | 2022-08-26 | — | — | CN | disclosed |
| EP-4031522-A1 | LIPIDOIDS FOR NUCLEIC ACID TRANSFECTION AND USE THEREOF | Ustav Organicke Chemie a Biochemie AV CR, v.v.i. (CZ) | 2022-07-27 | — | — | EP | disclosed |
| WO-2022063350-A1 | LIPIDOIDS FOR NUCLEIC ACID TRANSFECTION AND USE THEREOF | USTAV ORGANICKE CHEMIE A BIOCHEMIE AV CR, V. V. I. (CZ) | 2022-03-31 | — | — | WO | disclosed |
| US-20110117164-A1 | Use of Additive Sites to Control Nitric Oxide Release from Nitric Oxide Donors Contained within Polymers | NATIONAL INSTITUTES OF HEALTH-DIRECTOR DEITR | 2011-05-19 | — | — | US | disclosed |
| US-20060008529-A1 | Use of additive sites to control nitric oxide release from nitric oxide donors contained within polymers | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2006-01-12 | — | — | US | disclosed |
| EP-0584624-B1 | Segmented N-alkylated polyurethane amides | BAYER AG (DE) | 1998-04-29 | — | — | EP | disclosed |
| US-5391641-A | Molding materials | BAYER AKTIENGESELLSCHAFT (DE) | 1995-02-21 | — | — | US | disclosed |
| EP-0584624-A2 | Segmented N-alkylated polyurethane amides | BAYER AG (DE) | 1994-03-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240335559-A1 | CYCLOHEXANE LIPIDOIDS FOR NUCLEIC ACID TRANSFECTION AND USE THEREOF | SGMS2, NR1H3, SGMS1 | DNM1 1794/4885TSHR 2067/4885MEN1 2436/4885 |
| US-20230265049-A1 | Lipidoids for Nucleic Acid Transfection and Use Thereof | NPC1L1, CETP, NR1H2 | DNM1 1584/4885TSHR 1316/4885MEN1 2470/4885 |
| US-20110117164-A1 | Use of Additive Sites to Control Nitric Oxide Release from Nitric Oxide Donors Contained within Polymers | NOS1, NOS2, NOS3 | DNM1 2870/4885TSHR 4279/4885MEN1 2883/4885 |
| US-12559450-B2 | Lipidoids for nucleic acid transfection and use thereof | NPC1, NSUN3, NSUN2 | DNM1 1276/4885TSHR 1218/4885MEN1 1839/4885 |
| US-12605464-B2 | Cyclohexane lipidoids for nucleic acid transfection and use thereof | NR1H2, NPC1, NR1H3 | DNM1 1010/4885TSHR 2631/4885MEN1 2701/4885 |
| US-20060008529-A1 | Use of additive sites to control nitric oxide release from nitric oxide donors contained within polymers | NOS1, NOS2, NOS3 | DNM1 2870/4885TSHR 4279/4885MEN1 2883/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.